ebomi
Colour theme
Sign in
Insider · CIK 0001479386

Viswanathan Ravi

CIK 0001479386 Name as filed on the most recent filing

Filed as Viswanathan Ravi (48)

83 transaction lines · from 48 filings · filed 2011-11-22 to 2018-10-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

79 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2016-10-31 P, Open-market purchase Ra Pharmaceuticals, Inc.RARX 4,400,006, acquired Open Form 4 filing 0001209191-16-147490
2016-07-29 P, Open-market purchase Interleukin Genetics IncILIU 2,000,000, acquired Open Form 4 filing 0001209191-16-134937
2016-07-18 P, Open-market purchase Ardelyx, Inc.ARDX 2 lines 13,333,338, acquired Open Form 4 filing 0001209191-16-133493
2016-03-18 P, Open-market purchase Tesaro, Inc.TSRO 2 lines 49,999,993, acquired Open Form 4 filing 0001209191-16-109545
2016-01-13 P, Open-market purchase Ardelyx, Inc.ARDX 2 lines 10,000,000, acquired Open Form 4 filing 0001209191-16-091436
2016-01-12 P, Open-market purchase Epizyme, Inc.EPZM 9,999,999, acquired Open Form 4 filing 0001209191-16-091074
2015-10-06 P, Open-market purchase Mirna Therapeutics, Inc.MIRN 5,999,994, acquired Open Form 4 filing 0001209191-15-074314
2015-06-15 S, Open-market sale Tesaro, Inc.TSRO 30,393, disposed Open Form 4 filing 0001181431-15-008321
2015-06-12 S, Open-market sale Tesaro, Inc.TSRO 18,323, disposed Open Form 4 filing 0001181431-15-008321
2015-02-04 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 5,000,000, acquired Open Form 4 filing 0001181431-15-002011
2014-12-23 P, Open-market purchase Interleukin Genetics IncILIU 1,992,857, acquired Open Form 4 filing 0001181431-14-039773
2014-10-08 P, Open-market purchase Dermira, Inc.DERM 1,105,792, acquired Open Form 4 filing 0001181431-14-034010
2014-08-18 S, Open-market sale Epizyme, Inc.EPZM 15,396, disposed Open Form 4 filing 0001181431-14-029537
2014-08-18 S, Open-market sale Cvent IncCVT 8,750, disposed Open Form 4 filing 0001181431-14-029552
2014-08-06 P, Open-market purchase Loxo Oncology, Inc.LOXO 2,999,997, acquired Open Form 4 filing 0001181431-14-028433
2014-07-22 P, Open-market purchase Roka BioScience, Inc.ROKA 4,599,996, acquired Open Form 4 filing 0001181431-14-027153
2014-01-21 S, Open-market sale Cvent IncCVT 6,030,989, disposed Open Form 4 filing 0001181431-14-003494
2014-01-16 S, Open-market sale Cvent IncCVT 40,206,910, disposed Open Form 4 filing 0001181431-14-003135
2014-01-15 P, Open-market purchase Glycomimetics IncGLYC 4,100,000, acquired Open Form 4 filing 0001181431-14-002531
2013-11-15 P, Open-market purchase Epizyme, Inc.EPZM 2 lines 979,454, acquired Open Form 4 filing 0001181431-13-059382
2013-11-14 P, Open-market purchase Epizyme, Inc.EPZM 3 lines 7,018,527, acquired Open Form 4 filing 0001181431-13-059382
2013-06-05 P, Open-market purchase Epizyme, Inc.EPZM 6,000,000, acquired Open Form 4 filing 0001181431-13-033519
2013-04-16 S, Open-market sale Omthera Pharmaceuticals, Inc.OMTH 1,568, disposed Open Form 4 filing 0001181431-13-022599
2013-04-16 P, Open-market purchase Omthera Pharmaceuticals, Inc.OMTH 5,000,000, acquired Open Form 4 filing 0001181431-13-022599
2012-10-29 S, Open-market sale Millennial Media Inc.MM 21,478,252, disposed Open Form 4 filing 0001181431-12-055834
2012-07-03 P, Open-market purchase Tesaro, Inc.TSRO 14,999,999, acquired Open Form 4 filing 0001181431-12-039180
2011-11-21 P, Open-market purchase Clovis Oncology, Inc.CLVS 17,111,887, acquired Open Form 4 filing 0001181431-11-057267

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 67
  • Open-market sale 12
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Viswanathan Ravi, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001479386

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.